Home › Atherosclerosis › Missouri › Kansas City

Atherosclerosis clinical trials in Kansas City, MO

4 studies for Atherosclerosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3

Alliance for Multispecialty Research - Kansas City, Kansas City
Kansas City Veterans Affairs Medical Center, Kansas City

Ages 45 to 99 · All sexes · Updated Oct 5, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

RecruitingPhase 2/3

Clinical Research Consultants, Kansas City
Kansas City VA Medical Center, Kansas City
DCI-Rockhill, Kansas City

Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

RecruitingPhase 3

Research Site, Kansas City
Research Site, Kansas City

Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

RecruitingPhase 4

Kansas City VA Medical Center, Kansas City, MO, Kansas City

Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198

About Atherosclerosis

Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.

More about Atherosclerosis on MedlinePlus

Atherosclerosis trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.